Altimmune Inc. (ALT) News Headlines

▮ More

Date

Headline

10/15/2020 2:06:24 AM FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade

10/13/2020 10:14:16 AM Stock Alert: Altimmune Jumps 19%

10/13/2020 6:24:46 AM Pre-market Movers In Healthcare Sector: EARS, ALT, IVA, ENLV, EBS...

9/25/2020 10:42:35 AM Stock Alert: Altimmune Ascends 10%

9/14/2020 10:57:37 AM Stock Alert: Altimmune Up 10%

9/1/2020 7:17:01 AM Altimmune Announces Completion Of Multiple Dose Toxicity, Toxicokinetic Studies Of ALT-801

8/26/2020 7:02:46 AM Altimmune Announces Preclinical Data Presentation On ALT-801

8/15/2020 10:51:37 AM 4 Stocks That Delivered Over 1,000% Returns

8/7/2020 7:15:19 AM Altimmune Completes Enrollment In Its Phase 1b Clinical Trial Of NasoShield

7/31/2020 2:50:46 AM PRPO Up 400% As It Readies For Rollout Of COVID-19 Test, LXRX Realigns Business, VRTX Boosts Outlook

7/28/2020 3:06:03 AM MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30

7/14/2020 2:30:51 AM EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4

7/13/2020 9:24:26 AM Stock Alert: Altimmune Shares Up 22% In Premarket

7/10/2020 2:18:52 AM Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here

7/9/2020 7:19:48 AM Altimmune Enters Teaming Agreement With DynPort Vaccine Company

7/9/2020 4:18:40 AM Altimmune's (ALT) Astounding Journey From $1 To $20 In Just Few Months

6/30/2020 7:11:18 AM Altimmune Announces Dosing Of First Patient In Phase 1b Clinical Trial Of NasoShield

6/29/2020 7:53:03 AM DoD Awards $4.7 Mln To Altimmune To Fund Phase 1/2 Clinical Trial Of T-COVID - Quick Facts

6/29/2020 7:46:43 AM Stock Alert: Altimmune Shares Up 20% In Premarket On $4.7 Mln Award From US DoD

6/29/2020 7:40:16 AM Altimmune Gets Award From DoD To Fund Phase 1/2 Clinical Trial Of T-COVID